Gerlinde van der Maten (Former)
1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
CX3C chemokine receptor 1 deficiency modulates microglia morphology but does not affect lesion size and short-term deficits after experimental stroke
(
- Contribution to journal › Article
- 2015
-
Mark
Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke.
(
- Contribution to journal › Article